Winstanley Enterprises is a leading commercial real estate developer based in New England, specializing in the acquisition and development of properties across various asset classes such as industrial, life science, retail, office, and multi-family. With a portfolio comprising over 125 properties and 20 million square feet, they have a proven track record of providing significant capital appreciation for their institutional and equity investors through their unique approach of value-added construction management services and high-quality tenant service.
One of their notable successes includes the development of 100 College Street, a pioneering $200 million, 513,000 square foot life-science building in New Haven, which now serves as the worldwide headquarters for Alexion Pharmaceuticals (now part of AstraZeneca) and Yale University. This achievement has not only propelled the growth of the life-science industry in New Haven and Connecticut but has also led to the ongoing development of 101 College Street, a $250 million, 525,000 square foot life-science building. Winstanley's commitment to sustainability is evident in their LEED-certified projects, such as the 14-story office laboratory building at 100 College Street, which features a rooftop garden and an 850-space parking garage.
Generated from the website